Ken Griffin Omeros Corp Transaction History
Citadel Advisors LLC
- $483 Billion
- Q2 2024
A detailed history of Ken Griffin (Citadel Advisors LLC) transactions in Omeros Corp stock. As of the latest transaction made, Citadel Advisors LLC holds 62,600 shares of OMER stock, worth $247,896. This represents 0.0% of its overall portfolio holdings.
Number of Shares
62,600
Previous 29,300
113.65%
Holding current value
$247,896
Previous $101,000
151.49%
% of portfolio
0.0%
Previous 0.0%
Shares
24 transactions
Others Institutions Holding OMER
# of Institutions
112Shares Held
25.5MCall Options Held
317KPut Options Held
556K-
Ingalls & Snyder LLC New York, NY4.59MShares$18.2 Million0.8% of portfolio
-
Black Rock Inc. New York, NY4.1MShares$16.2 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.22MShares$12.7 Million0.0% of portfolio
-
Stifel Financial Corp St. Louis, MO1.9MShares$7.53 Million0.01% of portfolio
-
D. E. Shaw & Co., Inc. New York, NY1.58MShares$6.24 Million0.01% of portfolio
About OMEROS CORP
- Ticker OMER
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 62,730,000
- Market Cap $248M
- Description
- Omeros Corporation, a commercial-stage biopharmaceutical company, discovers, develops, and commercializes small-molecule and protein therapeutics, and orphan indications targeting inflammation, complement-mediated diseases, cancers related to dysfunction of the immune system, and addictive and compulsive disorders. The company's clinical program...